John Murphy, PhD, on April 20 was appointed chief technology officer of GTX Medical BV, a device company specializing in neuromodulation therapies for spinal cord injuries.
Spinal Tech
Orthopedic implant manufacturer Conformis recently received a $4.7 million loan through the Small Business Association to help maintain liquidity during the COVID-19 pandemic.
Precision Spine on April 20 launched Reform MC, a posterior lumbar fusion system.
The FDA on April 14 provided Astura Medical 510(k) clearance for its Sirion lateral lumbar interbody fusion system.
The spinal allograft market is expected to increase from $2.5 billion in 2019 to $3.9 billion by the end of 2025, according to new data published by ReportLinker.
The FDA cleared 19 spine devices in March 2020.
Johnson & Johnson reported orthopedic sales in the U.S. were down 5.2 percent in the first quarter and all subspecialty lines reported drops as well due to the coronavirus.
Here are eight key notes on spine and orthopedic device companies:
The FDA approved Centinel Spine's prodisc L lumbar total disc replacement device for two-level indications on April 14.
Biotechnology company Vomaris plans to expedite the approval of its bioelectric V.Dox system after research has indicated that viruses are killed upon exposure to the technology, the Daily Independent reports.
